Anti-fibrinolytics Trialists Collaboration
Established in 2017, the Anti-fibrinolytics Trialists Collaboration (ATC) is an international collaboration to conduct individual patient data meta-analyses of results from randomised trials of anti-fibrinolytics versus placebo.
The lead investigators of all completed and ongoing trials of anti-fibrinolytics that involve 1000 or more patients are invited to join the collaboration and contribute individual patient data.
The ATC has been set up to address important clinical questions regarding the effects of anti-fibrinolytics that cannot be answered by individual trials or by standard meta-analyses based on aggregate data.
The ATC is co-ordinated from the London School of Hygiene & Tropical Medicine Clinical Trials Unit.
Katharine Ker, ATC co-ordinator